机构:[1]Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University首都医科大学?脑血管病研究所首都医科大学宣武医院[2]Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing, China[3]Division of Pharmaceutical Sciences, Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA, USA
Neuronal cell cycle re-entry is pro-apoptotic. The neuroprotective effects and anti-apoptosis of ischemic postconditioning (IPostC) are well established but the underlying mechanism is still unknown. We explored this critical gap in the present study by genomic comparison of ischemic rat cortex following transient middle cerebral artery occlusion (tMCAO) alone and tMCAO+IPostC. The gene expression profiles of ipsilateral cortices were subjected to microarray analysis. RT-PCR, immunoblotting, and immunofluorescence were subsequently used to quantify or localize the cell proliferation marker proliferating cell nuclear antigen (PCNA), positive and negative cell cycle regulators, and related signaling molecules. Microarray analysis revealed that tMCAO-induced transcriptional changes in 40 cell cycle regulators were ameliorated by IPostC, suggesting that IPostC reversed neuronal cell cycle re-entry. IPostC reversed the rise in mRNA levels of positive cell cycle regulators ccnb1, cdk1, cdca2, cdca3, and cdca7. Elevations in cyclin D1 and neuronal cyclin A2 were similarly inhibited as well. tMCAO-induced phosphorylation of extracellular signal-regulated kinase (p-ERK), glycogen synthase kinase-3 beta (p-GSK-3 beta), and cAMP response element binding protein (p-CREB) were also all depressed by IPostC. Furthermore, p-ERK colocalized with neuronal cyclin A2. The present study demonstrates the potent inhibitory effect of IPostC treatment on tMCAO-induced cell-cycle reentry and on ERK/CREB and GSK-3 beta/CREB signaling. Because neuronal cell cycle re-entry is pro-apoptotic, these findings lend insight into potential mechanisms underlying neuroprotection of IPostC.
基金:
Natural Science Foundation in China (30770743, 30870854, and 81071058)
第一作者机构:[1]Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University[2]Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing, China
共同第一作者:
通讯作者:
通讯机构:[*1]Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, 45 Changchun St, Beijing, 100053, China